The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_000277.3(PAH):c.443_509+1del

CA229552

102681 (ClinVar)

Gene: PAH
Condition: phenylketonuria
Inheritance Mode: Autosomal recessive inheritance
UUID: 1bf52a23-a03e-4000-871d-889b26af8ff3

HGVS expressions

NM_000277.3:c.443_509+1del
NM_000277.3(PAH):c.443_509+1del
NC_000012.12:g.102866596_102866663del
CM000674.2:g.102866596_102866663del
NC_000012.11:g.103260374_103260441del
CM000674.1:g.103260374_103260441del
NC_000012.10:g.101784504_101784571del
NG_008690.1:g.55941_56008del
NG_008690.2:g.96749_96816del
ENST00000553106.6:c.443_509+1del
ENST00000307000.7:c.428_494+1del
ENST00000549111.5:n.539_605+1del
ENST00000551988.5:n.530+10800_530+10867del
ENST00000553106.5:c.443_509+1del
NM_000277.1:c.443_509+1del
NM_000277.2:c.443_509+1del
NM_001354304.1:c.443_509+1del
NM_001354304.2:c.443_509+1del

Pathogenic

Met criteria codes 3
PVS1 PM2 PP4_Moderate

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Phenylketonuria VCEP
The c.443_509+1del (p.Ex5del) variant in PAH is a deletion of exon 5 and is predicted to lead to a frameshift at His170, premature protein truncation, and NMD (PVS1). It is absent from ethnically diverse control databases, including gnomAD (structural variant version, gnomAD SVs v2.1) (PM2). It has been previously reported in one patient with PKU (BH4 deficiency excluded by sequencing of the genes in the BH4 cofactor metabolism pathway) (PP4_Moderate) (PMID: 23942198) in presumed trans with the p.G332R variant (unclassified/VUS). It is also noted in ClinVar (ID 102681) without a classification. Classification: Pathogenic Supporting Criteria: PVS1; PM2; PP4_Moderate
Met criteria codes
PVS1
The c.443_509+1del (p.Ex5del) variant in PAH is a deletion of exon 5 and is predicted to lead to a frameshift at His170, premature protein truncation, and NMD (PVS1).
PM2
It is absent from ethnically diverse control databases, including gnomAD (structural variant version, gnomAD SVs v2.1) (PM2).
PP4_Moderate
It has been previously reported in one patient with PKU (BH4 deficiency excluded by sequencing of the genes in the BH4 cofactor metabolism pathway) (PP4_Moderate) (PMID: 23942198) in presumed trans with the p.G332R variant (unclassified/VUS).
Approved on: 2020-05-22
Published on: 2021-03-21
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.